Search research articles
Contact Us
Filters
Showing results (401-410 of 433) with videos related to
Page
of 44
Sort By:
The Analyst
|
August 31, 2013
Enhanced imaging of developed fingerprints using mass spectrometry imaging
M J Bailey, M Ismail, S Bleay, et al.
Analytical Chemistry
|
November 21, 2019
Nanoextraction Coupled to Liquid Chromatography Mass Spectrometry Delivers Improved Spatially Resolved Analysis
Holly-May Lewis, Roger P Webb, Guido F Verbeck, et al.
IEEE Transactions on Visualization and Computer Graphics
|
August 16, 2017
Cognitive Cost of Using Augmented Reality Displays
James Baumeister, Seung Youb Ssin, Neven A M ElSayed, et al.
Neoplasia (New York, N.Y.)
|
April 15, 2014
Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation
Artem D Berezovsky, Laila M Poisson, David Cherba, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
November 11, 1998
Molecular and structural biology of thyroid hormone receptors
J W Apriletti, R C Ribeiro, R L Wagner, et al.
FEBS Letters
|
December 17, 2011
Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5
Suzanne R Kalb, Jakub Baudys, Robert P Webb, et al.
Plos One
|
January 13, 2012
A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
Jean Mukherjee, Jacqueline M Tremblay, Clinton E Leysath, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
September 25, 2004
Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain
F M Nunes, R Aparicio, M A M Santos, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 4, 2017
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A
William A Harrell, Rebecca C Vieira, Susan M Ensel, et al.
International Journal of Obesity (2005)
|
July 28, 2016
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
C S Filgueira, E Nicolov, R L Hood, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 433) with videos related to
Sort By:
Page
of 44
The Analyst
|
August 31, 2013
Enhanced imaging of developed fingerprints using mass spectrometry imaging
M J Bailey, M Ismail, S Bleay, et al.
Analytical Chemistry
|
November 21, 2019
Nanoextraction Coupled to Liquid Chromatography Mass Spectrometry Delivers Improved Spatially Resolved Analysis
Holly-May Lewis, Roger P Webb, Guido F Verbeck, et al.
IEEE Transactions on Visualization and Computer Graphics
|
August 16, 2017
Cognitive Cost of Using Augmented Reality Displays
James Baumeister, Seung Youb Ssin, Neven A M ElSayed, et al.
Neoplasia (New York, N.Y.)
|
April 15, 2014
Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation
Artem D Berezovsky, Laila M Poisson, David Cherba, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
November 11, 1998
Molecular and structural biology of thyroid hormone receptors
J W Apriletti, R C Ribeiro, R L Wagner, et al.
FEBS Letters
|
December 17, 2011
Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5
Suzanne R Kalb, Jakub Baudys, Robert P Webb, et al.
Plos One
|
January 13, 2012
A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model
Jean Mukherjee, Jacqueline M Tremblay, Clinton E Leysath, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
September 25, 2004
Crystallization and preliminary X-ray diffraction studies of isoform alpha1 of the human thyroid hormone receptor ligand-binding domain
F M Nunes, R Aparicio, M A M Santos, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 4, 2017
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A
William A Harrell, Rebecca C Vieira, Susan M Ensel, et al.
International Journal of Obesity (2005)
|
July 28, 2016
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
C S Filgueira, E Nicolov, R L Hood, et al.
Page
of 44